Phoenix Venture Partners’ affiliate

WaveFront Dynamics Inc. Initiates $3mm Series A Round to Fund Continued Development of Dynamic Wavefront Measurement System for Vision Correction

Retrieved on: 
Tuesday, August 25, 2020
Professional services, Health, Medical devices, Venture capital, Research, Science, Optical, Optics, Wavefront, Waves, WaveDyn, Tramway Venture Partners, Phoenix Venture Partners’ affiliate

WaveFront Dynamics Inc. (WaveDyn), an early stage ophthalmic medical device company, today announced the first close of a $3 million Series A financing round.

Key Points: 
  • WaveFront Dynamics Inc. (WaveDyn), an early stage ophthalmic medical device company, today announced the first close of a $3 million Series A financing round.
  • The funds will support continued development of its ophthalmic measurement device with dynamic wavefront technology and subsequent clinical studies.
  • The company will leverage its dynamic wavefront measurement capabilities to create ophthalmic treatment solutions for patients with complex visual dysfunction.
  • The dynamic wavefront guided treatment has the potential for improving the vision of hundreds of thousands of patients in the US alone, said Neal.